Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
10x genomics
abbvie
allergan
amgen
anemia
antibiotic
antisense oligonucleotide
astrazeneca
autism
autism spectrum disorder
avexis
benzodiazepines
blackstone group
blackstone life sciences
boston
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
clostridium difficile
columbia university
community-acquired bacterial pneumonia
dana hilt
daprodustat
david chacko
david goldstein
What
drugs
2
×
aims
august
backed
bio
biotech
busy
cause
ceo
days
decisions
devices
epilepsy
fda
genes
genetic
legacy
links
marcio
medicines
mutations
neuro
new
news
nods
opioid
past
praxis
precision
regulatory
research
roundup
sarepta’s
seven
shkreli’s
slow
souza
stop
stumble
suits
Language
unset
Current search:
biogen
×
drugs
×
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More